300+ investors in your industry, stage, and region Get
Any industry
Community
Proptech
Biotech
Climate
Artificial Intelligence
Media (Entertainment)
Impact
FinTech
Marketplace
EdTech
Consumer
Agriculture (AgTech)
Web3
Clean Energy
B2B
Organic Food
Big Data
Video Games
Payments
Celebrity
Franchise
Mobile
Local
Social Network
Platforms
Crowdfunding
CleanTech
Film
Theatre
Life Science
Non Profit
Transportation
Gaming
Energy
Hardware
Health Care
Enterprise
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Publishing
Sporting Goods
Oil and Gas
Education
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Financial Services
Photography
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Blockchain
Legal
Android
Social Impact
Google
Construction
Sports
eSports
Enterprise Software
Email
Wellness
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Biotechnology
Medical Device
Wine and Spirits
Automotive
Social
InsurTech
SaaS
Software
Any country
Qatar
South Korea
Africa
Asia
LATAM
Europe
Oceania
Middle East
Ireland
Singapore
Indonesia
Spain
Saudi Arabia
Belarus
Belgium
Colombia
Denmark
Ecuador
Czech Republic
Estonia
Ghana
Ethiopia
Finland
Barbados
Italy
Jersey
Cayman Islands
Mali
Malaysia
Mauritius
Poland
Rwanda
Togo
Slovenia
San Marino
Tanzania
Thailand
Uruguay
Venezuela
Portugal
Azerbaijan
Namibia
Bolivia
Latvia
Cyprus
New Zealand
United States
Germany
Australia
India
United Kingdom
Canada
China
South Africa
Brazil
Japan
Sri Lanka
Vietnam
Argentina
Armenia
Austria
Bangladesh
Bahrain
Bulgaria
Bermuda
Chile
Cameroon
Switzerland
Belize
Costa Rica
Algeria
Georgia
Egypt
Hong Kong
Gibraltar
Faroe Islands
Greece
Croatia
France
Hungary
Kuwait
Israel
Lebanon
Cambodia
Kenya
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Morocco
Norway
Mexico
Panama
Malta
Peru
Philippines
Nicaragua
Pakistan
Russian Federation
Romania
Sweden
Serbia
Seychelles
Turkey
Puerto Rico
Sierra Leone
Senegal
Tunisia
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Taiwan
Ukraine
Zimbabwe
Bahamas
Guatemala
Iraq
Iceland
Nigeria
United Arab Emirates
Honduras
Isle of Man
Luxembourg
Oman
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 35 Life Science Angel Investors in United Kingdom (May 2026)

The most active angel investors investing in United Kingdom Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in United Kingdom Life Science startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Jonathan Milner
Angel
7 United Kingdom, United States, Canada Seed, Series A, Series B Biotechnology, Health Care, Medical $430k–$50M
Nadav Rosenberg
Angel
4 United Kingdom, Israel, Singapore Seed, Pre-Seed, Series A Biotechnology, Artificial Intelligence, Pharmaceutical $2M–$2M
Stefano Bernardi
Angel
3 Italy, France, Norway Seed, Pre-Seed Software, Biotechnology, Cryptocurrency $2M–$2M
Ed Parkinson
Angel
2 United Kingdom Seed Software, Health Care, Life Science
Jude Gomila
Angel
2 United States, United Kingdom, Canada Seed, Pre-Seed, Angel Software, Biotechnology, Information Technology $190k–$3.1M
Nicholas Edwards
Angel
2 United Kingdom Seed Medical, Health Care, Life Science
Mark Evans
Angel
2 United Kingdom, United States, The Netherlands Series A, Seed Software, E-Commerce, Health Care
Darrin Disley
Angel
2 United Kingdom Seed, Series A Biotechnology, Health Care, Big Data $430k–$3.7M
Ian Hogarth
Angel
2 United Kingdom, United States, Germany Seed, Pre-Seed, Series A Software, E-Commerce, Health Care $123k–$12M
Jan Hruska
Angel
2 United Kingdom Seed Medical, Health Care, Life Science
Rick Bernstein
Angel
1 United Kingdom Seed AgTech, Genetics, Agriculture
Michelle Tempest
Angel
1 United Kingdom Seed, Series A Health Care, Cannabis, Life Science
Andrew Fisher
Angel
1 United Kingdom Series A Medical, Life Science, Biotechnology
Will Martin
Angel
1 United Kingdom, United States Seed, Series A FinTech, Financial Services, Software $614k–$3.1M
Will Brooks
Angel
1 United Kingdom, United States Seed, Series A Financial Services, FinTech, Software $614k–$3.1M
Keith Willey
Angel
1 United Kingdom, Spain Seed, Angel, Pre-Seed Software, Media and Entertainment, Gaming $1.4M–$1.6M
Irina Elena Haivas
Angel
1 United Kingdom, Estonia, Germany Series A, Seed, Series B Health Care, Artificial Intelligence, Biotechnology
Nadav Ben-Chanoch
Angel
1 United States, United Kingdom, France Seed, Pre-Seed Software, Information Technology, Health Care $100k–$5M
Vishal Gulati
Angel
1 United Kingdom, Hungary Seed, Series A, Series B Biotechnology, Biopharma, Life Science
David Evans
Angel
1 Israel, United Kingdom Series A, Series D, Series E Rental, Medical, Software
Sharaf Yamani
Angel
1 India, United Kingdom Seed Biotechnology, Software, Life Science
Edward Lando
Angel
1 United States, France, United Kingdom Seed, Pre-Seed Software, Information Technology, Health Care $100k–$4.5M
Patrick Pichette
Angel
1 United Kingdom, Germany, United States Seed, Series B, Series A Artificial Intelligence, Machine Learning, Software
Michail Eleftheriou
Angel
1 United Kingdom Seed Software, Life Science, Biotechnology $150k–$900k
Jim Warwick
Angel
1 United Kingdom Seed Life Science, Biotechnology
Fiona Pathiraja
Angel
1 United Kingdom, Germany, Armenia Pre-Seed, Seed, Series A Health Care, Biotechnology, Wellness $1.5M–$2.5M
Sophia Bendz
Angel
1 Sweden, United Kingdom, United States Seed, Pre-Seed Health Care, Software, Apps $1.1M–$3.6M
Jon Oringer
Angel
1 United States, France, United Kingdom Seed, Pre-Seed Software, Information Technology, E-Commerce $80k–$9.3M
Robert Kopple
Angel
1 United States, United Kingdom Convertible Note FinTech, Finance, Life Science
Matt Clifford
Angel
1 United Kingdom, India, United States Seed, Pre-Seed Software, FinTech, SaaS $1.4M–$1.8M
John Anthony Knight
Angel
1 United Kingdom Seed Software, Life Science, Biotechnology
David Lucas
Angel
1 United Kingdom Seed Software, Life Science, Biotechnology
Simon Galbraith
Angel
1 Croatia, United Kingdom Pre-Seed Software, Health Care, Life Science
Damien Lane
Angel
1 United Kingdom, Ireland, United States Seed, Pre-Seed, Series A Software, Information Technology, SaaS $442k–$5.7M
Sami Mikati
Angel
1 India, United Kingdom Seed Biotechnology, Software, Life Science
Access all 47 angel investors in United Kingdom Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Jonathan Milner
Angel · Cambridge, Massachusetts, United States · 7 investments in United Kingdom Life Science startups

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Canada

Investor stats

  • Total investments: 44
  • Round size: Seed $430k–$10M; Series A $1.8M–$18M; Series B $1.8M–$50M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
  • Pencil Biosciences — Next Generation Genome Editing Tool
Show all investments...

Nadav Rosenberg
Angel · London, England, United Kingdom · 4 investments in United Kingdom Life Science startups

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, Pharmaceutical
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, Israel, Singapore

Investor stats

  • Total investments: 13
  • Round size: Pre-Seed $2M–$2M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • thymia — Making mental health as objectively measurable as physical health.
  • Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
  • Loops — Loops is a no-code analytics platform that provides product and data teams with growth opportunities hidden in their data.
Show all investments...

Stefano Bernardi
Angel · San Francisco, California, United States · 3 investments in United Kingdom Life Science startups

Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Cryptocurrency
  • Stage:Seed, Pre-Seed
  • Geography: Italy, France, Norway

Investor stats

  • Total investments: 13
  • Round size: Pre-Seed $2M–$2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Freatic — We bridge the gap between individuals with untapped knowledge and actors who can take advantage of these opportunities.
  • Eden Bio — Eden Bio is a biotech using machine learning to guide the genetic engineering of microorganism strain optimisation, improving protein yield.
  • CaSRevolution — A novel disease-modifying approach against neurodegeneration
Show all investments...

Ed Parkinson
Angel · 2 investments in United Kingdom Life Science startups

Ed Parkinson

Show more...

Investment focus

  • Industry: Software, Health Care, Life Science
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Antiverse — Designing biologics for 100 challenging targets
Show all investments...

Jude Gomila
Angel · San Francisco, California, United States · 2 investments in United Kingdom Life Science startups

Jude Gomila is currently CEO and Founder of the startup Golden.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 50
  • Round size: Seed $1.2M–$3.1M; Angel $190k–$1.3M; Pre-Seed $1.2M–$2M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
  • Monitaur — Reduce operational overhead, improve security, optimize performance, and deliver amazing customer experiences with our end-to-end, hybrid observability & APM platform built for decentralized apps and infrastructure.
  • Gradia Health — Gradia is an integrated, concierge care platform designed for clinics to support patients with chronic conditions.
Show all investments...

Nicholas Edwards
Angel · Oxford, Oxfordshire, United Kingdom · 2 investments in United Kingdom Life Science startups

Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Show all investments...

Mark Evans
Angel · London, England, United Kingdom · 2 investments in United Kingdom Life Science startups

Mark is currently a Founding Partner and LP and Investment Committee member at Kindred Capital, a European Seed-Stage Venture fund, based in London. He was a General Partner at Balderton Capital/ Benchmark Europe from 2002 through 2015, and an EIR at Benchmark Capital in 1999/2000.He spent the prior 15 years @ Goldman Sachs, where hewas a General Partner and Management Committee member. He studied Economics at both University of Oxford and Queen's University in Canada.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Health Care
  • Stage:Series A, Seed
  • Geography: United Kingdom, United States, The Netherlands

Investor stats

  • Total investments: 37
  • Lead/follow: no public data

Portfolio highlights

  • ONI — ONI is a pioneer of super-resolution microscopy, making this advanced technology accessible to new generations of researchers. The Nanoimager, the world's first benchtop sized super-resolution microscope, delivers a step change in usability and precision. This, together with our next-generation consumable products will empower academicresearchers, clinicians and scientists to on a path to discovery.The microscope offers easy access to a range of super-resolution techniques including dSTORM and PALM, as well as smFRET, single-particle tracking and confocal.The company's achievements have been recognised by FastTrack100 who named ONI on their 2018 list of 10 Disruptors to Watch and ONI won Best Business Start-up at the 2018 IOP Awards. More and more life science researchers and pharma companies are taking an interest in ONI and it now has customers using its products in leading laboratories across the globe, including the Universities of Oxford, Cambridge and Harvard.ONI has a restless enthusiasm to make the world a better place. Our ambition is to bring super-resolution fluorescence imaging to a new community of researchers and we are removing barriers to make science more effective, accessible and affordable. Our vision is to accelerate scientific discovery and fight disease by enabling everyone to visualize, understand and share the microscopic details of life.
  • Ufonia — Ufonia is replacing routine patient healthcare interactions with next-generation automated phone calls.
  • Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
Show all investments...

Darrin Disley
Angel · Cambridge, Cambridgeshire, United Kingdom · 2 investments in United Kingdom Life Science startups

Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Big Data
  • Stage:Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 4
  • Round size: Seed $430k–$3.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Show all investments...

Ian Hogarth
Angel · London, England, United Kingdom · 2 investments in United Kingdom Life Science startups

Ian got a master's in machine learning at Cambridge and loves dystopian robot takeover narratives. Seven years ago, Ian realized being a choirboy came with no street cred, so he started DJing hip-hop, funk, drum & bass, and grime. Ian quit his job at Bain & Company, Singapore to start Songkick.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 40
  • Round size: Seed $1.5M–$12M; Pre-Seed $123k–$1.4M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
  • The Garden — The Garden is an online media company.
  • Condense — Live-streamed volumetric video into game engines
Show all investments...

Jan Hruska
Angel · 2 investments in United Kingdom Life Science startups

Jan Hruska

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Rick Bernstein
Angel · North Myrtle Beach, South Carolina, United States · 1 investments in United Kingdom Life Science startups

Rick Bernstein is the Chief Commercial Officer for MedNet responsible for the development of the commercial infrastructure and strategy for MedNet, a healthcare technology company specializing in eClinical solutions for the global life sciences industry. Rick is currently leading the development of an optimized sales, business development, anddistribution strategy to drive aggressive growth across key market segments, including CROs and pharmaceutical, medical device and biotechnology sponsors.

Show more...

Investment focus

  • Industry: AgTech, Genetics, Agriculture
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Farmless — A farmless fermentation platform has the potential to create an entirely new food repertoire, producing proteins, carbohydrates, beneficial fats, vitamins, and minerals from the ground up," explained Oner. "We are creating a new interface between food and electricity by domesticating microbes chosen for their food properties and abilityto grow on renewable energy-based feedstocks.
  • Phytoform Labs — Phytoform Labs is improving crops to make agriculture more sustainable and nutritious
Show all investments...

Michelle Tempest
Angel · 1 investments in United Kingdom Life Science startups

Michelle Tempest

Show more...

Investment focus

  • Industry: Health Care, Cannabis, Life Science
  • Stage:Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Daye — Sustainable, clinically validated organic CBD tampons and ProViotics for vaginal health, delivered to your door. Good for your body and the environment.
  • Medwise.ai — Medwise.ai is the Google for doctors.
Show all investments...

Andrew Fisher
Angel · Brighton, East Sussex, United Kingdom · 1 investments in United Kingdom Life Science startups

As an Executive Vice President at Wesley Clover, Andrew currently manages a portfolio of ICT and Digital Media companies globally. In addition he also acts as a business prime for the Wesley Clover affiliate program.Andrew connects teams of new graduates with tier one Network Operator, Service Provider and Communications EquipmentManufactures globally. These partnerships provide invaluable customer insight and a route to market for each of the Affiliates. Through these partnerships, each party realizes time to revenue, time to market and engine for innovation advantage.Andrew serves on the Board of Directors for March Entertainment, Benbria and Teldio Corporations. He is also a member of the Advisory board for the Canadian Digital Media Network and the Canadian Department of Foreign Affairs and International Trade Information and Communications Technologies.Andrew is an honors graduate from the University of British Columbia, with an academic background in Computer Science, Engineering and Economics.

Show more...

Investment focus

  • Industry: Medical, Life Science, Biotechnology
  • Stage:Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • MIP Diagnostics — MIP Diagnostics develop and manufacture molecularly imprinted polymers (nanoMIPs) that act as synthetic alternatives to antibodies for IVD and other industries.
Show all investments...

Will Martin
Angel · London, England, United Kingdom · 1 investments in United Kingdom Life Science startups

Will Martin - Founder and Director @ Portfolio Ventures

Show more...

Investment focus

  • Industry: FinTech, Financial Services, Software
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 65
  • Round size: Seed $614k–$2.8M; Series A $2.1M–$3.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Bequest — We're building a better way to protect you and your family, starting with personalised pay-as-you-go life insurance. Backed by Aviva.
  • Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
  • Robin AI — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.
Show all investments...

Will Brooks
Angel · London, England, United Kingdom · 1 investments in United Kingdom Life Science startups

Will Brooks - Founder & Director @ Portfolio Ventures

Show more...

Investment focus

  • Industry: Financial Services, FinTech, Software
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 66
  • Round size: Seed $614k–$2.8M; Series A $2.1M–$3.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Bequest — We're building a better way to protect you and your family, starting with personalised pay-as-you-go life insurance. Backed by Aviva.
  • Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
  • Robin AI — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.
Show all investments...

Keith Willey
Angel · London, England, United Kingdom · 1 investments in United Kingdom Life Science startups

Keith is an associate professor of strategic and international management and entrepreneurship at London Business School as well as a senior lecturer at University College London. He also holds various non-executive directorships and advisory roles. His career has spanned academia, consulting, investing and hands-on operational roles withinindustry and the venture capital world.

Show more...

Investment focus

  • Industry: Software, Media and Entertainment, Gaming
  • Stage:Seed, Angel, Pre-Seed
  • Geography: United Kingdom, Spain

Investor stats

  • Total investments: 8
  • Round size: Seed $1.4M–$1.6M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • 5Mins — 5Mins is the new microlearning platform that helps your employees build in-demand skills fast with AI-powered personalisation and advanced gamification.
  • NumberEight — Privacy-friendly mobile app monetization and analytics for app publishers, ad suppliers and SSPs. Know your users with intelligent first party data: specialized mobex AI for contextual advertising.
  • Arthur Online — A complete web-based solution supported by apps, to help with everything from finding and managing occupants to keeping track of rents and spending.
Show all investments...

Irina Elena Haivas
Angel · 1 investments in United Kingdom Life Science startups

Irina Haivas is a Principal. Based in London, she works on sourcing and due diligence of global investment opportunities.Irina focuses on businesses that use advanced technologies such as machine intelligence or robotics and automation, to transform large industries. She also focuses on the intersection of science and technology, including nextgeneration biology, as well as on companies in healthcare.Before joining Atomico, Irina was a growth and PE investor at GHO Capital Partners, where she invested, among others, in enterprise software and AI/ML businesses and focused on the intersection of science, healthcare and technology. Before that, Irina was part of the leadership team of Bain & Co. in Europe and the U.S., where she worked directly both with private equity firms on investment diligence, as well as with corporates on Innovation and Product, Go-to-Market, BD and acquisitions, and organisation scale-up. While at Bain she seconded in an operational role at Medtronic, one of the world’s largest medical engineering companies.Irina is a former surgeon, having studied medicine at Freiburg University in Germany and Iasi Medical University in Romania. She was a surgical fellow at Harvard Medical School before completing an MSc (Dist) in International Health Policy at London School of Economics.Irina speaks Romanian, English, advanced German, and conversational French.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, Estonia, Germany

Investor stats

  • Total investments: 8
  • Lead/follow: 88% lead, 12% follow

Portfolio highlights

  • Y42 — Find out now what the next leap for the analytics engineering workflow is
  • Daye — Sustainable, clinically validated organic CBD tampons and ProViotics for vaginal health, delivered to your door. Good for your body and the environment.
  • NFTPort — Simple & powerful NFT infrastructure and APIs. Mint NFTs, deploy contracts, get multi-chain NFT data and enhanced APIs. Grab your free API Key now: nftport.xyz
Show all investments...

Nadav Ben-Chanoch
Angel · Miami, Florida, United States · 1 investments in United Kingdom Life Science startups, 12 in the past 12 months

Nadav Ben-Chanoch - Partner @ Pareto Holdings

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Pre-Seed
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 147
  • Round size: Seed $120k–$5M; Pre-Seed $100k–$1.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Swaap — We build the market-neutral AMM protocol.
  • micro1 — We help companies hire and manage the best software engineers easily.
  • Skedway — Every work experience should be great! Skedway is the complete platform to optimize the hybrid work experience.
Show all investments...

Vishal Gulati
Angel · London, England, United Kingdom · 1 investments in United Kingdom Life Science startups

Vishal Gulati: Vishal serves as a venture partner specialising in digital health at DFJ Esprit, Europe's leading Silicon Valley style venture capital firm with over $1b under management. Since 2012, Vishal has been Europe’s leading promoter of investment into the emerging digital health sector and chairman of Digital Health Forum, whichsupports the best in class digital health companies to grow into global enterprises. Vishal serves on several boards including Horizon Discovery Group PLC (Cambridge, UK), a gene editing company; Fluidics Analytics (Cambridge, UK), a next gen protein discovery engine, Frameshift a healthcare information flow platform (London, UK) and EcoEos (San Francisco, USA), a consumer genomics business. His previous investments include Napo Pharmaceuticals, Glenmark, Renovo and Phagenesis.

Show more...

Investment focus

  • Industry: Biotechnology, Biopharma, Life Science
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, Hungary

Investor stats

  • Total investments: 7
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
  • evonetix — evonetix is a new spin-out company that is currently incubating in the centre of the world-renowned Cambridge cluster of high-tech and life science organisations. We are seeking to develop and commercialise a new approach to the synthesis of DNA to facilitate the fast-emerging and exciting field of synthetic biology. By employing novel techniqueswe are able to advance DNA synthesis to levels never before seen. Our engineering team has decades of experience developing high integrity automated systems. Our high calibre team brings together expertise from across the scientific and engineering disciplines.
  • Turbine — Turbine builds a platform to understand the inner mechanisms of cancer, enabling the discovery of novel protein targets, precision biomarkers, and better translation to patients. Turbine uses its proprietary Simulated Cell technology in combination with Artificial Intelligence to build a faster and deeper biological understanding of therapeutictargets or indications, untangling the complexity of cancer.
Show all investments...

David Evans
Angel · New York, New York, United States · 1 investments in United Kingdom Life Science startups

Principal at Apax Digital.

Show more...

Investment focus

  • Industry: Rental, Medical, Software
  • Stage:Series A, Series D, Series E
  • Geography: Israel, United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Guesty — Guesty simplifies the way property managers work.
  • MIP Diagnostics — MIP Diagnostics develop and manufacture molecularly imprinted polymers (nanoMIPs) that act as synthetic alternatives to antibodies for IVD and other industries.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Sharaf Yamani
Angel · London, England, United Kingdom · 1 investments in United Kingdom Life Science startups

Sharaf Yamani - Managing Director @ Windlesham Advisors

Show more...

Investment focus

  • Industry: Biotechnology, Software, Life Science
  • Stage:Seed
  • Geography: India, United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • CyGenica — CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics.
  • Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Show all investments...

Edward Lando
Angel · San Francisco, California, United States · 1 investments in United Kingdom Life Science startups, 17 in the past 12 months

Edward Lando is the Managing Partner at Pareto Holdings.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Pre-Seed
  • Geography: United States, France, United Kingdom

Investor stats

  • Total investments: 221
  • Round size: Seed $321k–$4.5M; Pre-Seed $100k–$1.9M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • micro1 — We help companies hire and manage the best software engineers easily.
  • Skedway — Every work experience should be great! Skedway is the complete platform to optimize the hybrid work experience.
  • NewHomesMate (formerly Propertymate) — Find, compare and buy a new construction home - all in one place.
Show all investments...

Patrick Pichette
Angel · London, England, United Kingdom · 1 investments in United Kingdom Life Science startups

Patrick Pichette currently Board Member at LightSpeed and Twitter. He is a former Google's chief financial officer, where he started in June of 2008. He has nearly 20 years of experience in financial operations and management in the telecommunications sector, including seven years at Bell Canada, which he joined in 2001 as executive vicepresident of planning and performance management.During his time at Bell Canada, he held various executive positions, including CFO from 2002 until the end of 2003, and was instrumental in the management of the most extensive communications network in Canada and its ongoing migration to a new national IP-based infrastructure.Prior to joining Bell Canada, Patrick was a partner at McKinsey & Company, where he was a lead member of McKinsey's North American Telecom Practice. He also served as vice president and chief financial officer of Call-Net Enterprises, a Canadian telecommunications company.Patrick earned a bachelor's degree in business administration from UniversitA© du Quebec A  MontrA©al. He holds a master's degree in philosophy, politics, and economics from Oxford University, where he attended as a Rhodes Scholar. He also serves on the board of Engineers Without Borders (Canada).

Show more...

Investment focus

  • Industry: Artificial Intelligence, Machine Learning, Software
  • Stage:Seed, Series B, Series A
  • Geography: United Kingdom, Germany, United States

Investor stats

  • Total investments: 19
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Apheris — Build ML-powered products using data that spans organizational or geographical boundaries, while ensuring compliance with regulation.
  • Unlikely AI — We are pioneering safe, trustworthy and powerful artificial intelligence
  • Vay — Vay is a leading teledriving company that aims to launch a unique, affordable, and sustainable door-to-door mobility service.
Show all investments...

Michail Eleftheriou
Angel · London, England, United Kingdom · 1 investments in United Kingdom Life Science startups

Michail Eleftheriou

Show more...

Investment focus

  • Industry: Software, Life Science, Biotechnology
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Round size: Seed $150k–$900k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
  • 2Go Mobile Now
Show all investments...

Jim Warwick
Angel · Cambridge, Cambridgeshire, United Kingdom · 1 investments in United Kingdom Life Science startups

Jim started work at Analysys Limited, a Cambridge-based telecommunications consultancy, heading up its IT, software and web development initiatives. Jim then joined Abcam as a Technical Director, and took over the operational management of the UK office as Managing Director in June 2004, working on both cost saving and efficiency improvementprojects. In 2009, Jim became Chief Operating Officer, with the responsibility for overseeing the operational strategy of the Group. Jim is a Director of Chesterton Community College, Chesterton Sports Centre Limited and Cambridge Nutraceuticals Limited. He has also taken up a non-executive position at Quartix Holdings Plc. Jim had over 15 years’ experience in developing and implementing IT systems and strategy before moving into a broader operational management role within Abcam.Here his skills have been particularly focused on developing a scalable operating model for Abcam which, supported by IT systems, has underpinned Abcam’s rapid growth over the past decade.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Qkine — Growth Factors made for stem cells Animal-free We control every step of protein manufacture ensuring all our products are completely animal-free Total transparency Stringent purity and bioactivity testing data for all proteins - know what you are giving your cells Protein innovation Our R&D team
Show all investments...

Fiona Pathiraja
Angel · 1 investments in United Kingdom Life Science startups

Fiona is Managing Partner at Crista Galli Ventures, an early stage healthtech VC fund based in London and Copenhagen.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Wellness
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United Kingdom, Germany, Armenia

Investor stats

  • Total investments: 11
  • Round size: Pre-Seed $1.5M–$2.5M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Melon — Save & organise content from any source. Follow experts and friends. Share your knowledge with others.
  • Bloom Money — Bloom Money is a savings club app designed to help growing communities in migrant communities and use technology to promote community, safety, and convenience.
  • Storia — Capture your thoughts and unleash your inner voice
Show all investments...

Sophia Bendz
Angel · Stockholm, Stockholms Lan, Sweden · 1 investments in United Kingdom Life Science startups

Sophia Bendz - Partner @ Cherry Ventures

Show more...

Investment focus

  • Industry: Health Care, Software, Apps
  • Stage:Seed, Pre-Seed
  • Geography: Sweden, United Kingdom, United States

Investor stats

  • Total investments: 39
  • Round size: Seed $1.1M–$3.6M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • mayk — Mayk sounds. Mayk music. Mayk noise. Mayk it... In an app.
  • Medoma — Medoma is a Swedish virtual ward company that offer patients acute hospital care in their home instead of in the hospital.
  • Wikifarmer — A free online knowledge library where professional or amateur farmers can find best practices on growing their fields more effectively and an online marketplace where farmers can sell their products to buyers directly. Our vision is to create a fair, transparent and profitable environment for all the farming world. Farmers are dedicating theirlives in cultivating their fields, but get the lowest value of all the sales cycle, so we believe they need to receive a more fair share. Buyers have the right to have more options and buy at better prices, so we want to be the ones to solve this inequality in both sides.
Show all investments...

Jon Oringer
Angel · Miami, Florida, United States · 1 investments in United Kingdom Life Science startups

Jon Oringer is the founder and chairman of Shutterstock.

Show more...

Investment focus

  • Industry: Software, Information Technology, E-Commerce
  • Stage:Seed, Pre-Seed
  • Geography: United States, France, United Kingdom

Investor stats

  • Total investments: 106
  • Round size: Seed $326k–$9.3M; Pre-Seed $80k–$3.2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Skedway — Every work experience should be great! Skedway is the complete platform to optimize the hybrid work experience.
  • Zamp — We give you freedom from sales tax! Eliminate the need to learn, manage or touch any part of the sales tax compliance process.
  • NewHomesMate (formerly Propertymate) — Find, compare and buy a new construction home - all in one place.
Show all investments...

Robert Kopple
Angel · Los Angeles, California, United States · 1 investments in United Kingdom Life Science startups

Robert Kopple

Show more...

Investment focus

  • Industry: FinTech, Finance, Life Science
  • Stage:Convertible Note
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Tradier — Tradier is a financial services cloud provider that offers a groundbreaking solution to serve platform providers, developers and investors. The Tradier solution features an innovative set of fully hosted APIs, modules, and "out of the box" tools that are leveraged by a growing list of providers.
  • ILC Therapeutics — ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.
Show all investments...

Matt Clifford
Angel · London, England, United Kingdom · 1 investments in United Kingdom Life Science startups

Matt co-founded EF after being a consultant at McKinsey & Co. Prior to EF Matt spent his time studying at MIT fuelled by an obsession with R, Python and unusual datasets. EF is the best place for Europe’s top technical individuals to meet and build world-changing startups in London.They select purely on the basis of technical talent, so youcan apply before you have a team or an idea. The intensive 6-month programme is designed to give you the best possible support in the first 200 days of your startup’s life.They have created over 40 startups now worth over $300 million. The startups are funded by some prestigious investors including Balderton Capital, Index Ventures, Octopus Investments and Y Combinator.

Show more...

Investment focus

  • Industry: Software, FinTech, SaaS
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, India, United States

Investor stats

  • Total investments: 21
  • Round size: Pre-Seed $1.4M–$1.8M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Koos — KOOS is a simple legal and technological solution for motivating and rewarding your community. Boost your growth by sharing success.
  • Patch — Patch is your new neighbourhood space for work, community, and events.
  • Flow Engineering — Requirements management, made collaborative
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
John Anthony Knight
Angel · 1 investments in United Kingdom Life Science startups

John Anthony Knight

Show more...

Investment focus

  • Industry: Software, Life Science, Biotechnology
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Show all investments...

David Lucas
Angel · 1 investments in United Kingdom Life Science startups

David Lucas

Show more...

Investment focus

  • Industry: Software, Life Science, Biotechnology
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Show all investments...

Simon Galbraith
Angel · Cambridge, Cambridgeshire, United Kingdom · 1 investments in United Kingdom Life Science startups

Simon is the joint founder and CEO of Redgate Software. Over the past 15 years, Simon has been part of Redgate’s growth from a 2 person firm operating out of a spare room to today’s 300 person outfit with hundreds of thousands of users. Although Simon’s responsibilities are primarily strategic, his background is technical with qualificationsincluding a PhD in physics from Cambridge University and former employment with Shell and ThornEMI.

Show more...

Investment focus

  • Industry: Software, Health Care, Life Science
  • Stage:Pre-Seed
  • Geography: Croatia, United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • BoobyBiome — BoobyBiome uses specialist expertise and research to develop a probiotic supplement for infants with compromised microbiomes. We aim to promote healthy infant development by recreating the beneficial bacteria associated with breast milk.
  • SysKit — Syskit is a software development company specialized in enterprise tools for Microsoft 365, SharePoint, Windows Server, Remote Desktop Services, Citrix.
Show all investments...

Damien Lane
Angel · London, England, United Kingdom · 1 investments in United Kingdom Life Science startups

Damien Lane has spent the last 20 years investing in private companies, both in Private Equity where he was a partner with Electra Partners, then at Octopus Ventures where he was a senior member of the investment team. Having made a number of angel investments, Damien co-founded Episode 1 with Simon and Adrian in 2012. While at Episode 1,Damien has led investments in Carwow, Scurri, Touch Surgery, Attest and Zipcube and loves working with early stage teams of entrepreneurs; helping them develop their early stage startup into a fast growth enterprises capable of raising more funding from later stage investors. When he is not trying to help businesses to implement an optimal approach to growth, Damien can mostly be found running around Hampstead Heath or the Coastal paths of Great Britain. Having trained obsessively to run a 2:52 Marathon in 2015, he is now trying to dip below 2:50, in the spirit of continuous improvement. Damien has an MBA from Cambridge University and a Masters degree in PE from Oxford University.

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, Ireland, United States

Investor stats

  • Total investments: 34
  • Round size: Seed $442k–$3.1M; Series A $3.2M–$5.7M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Narchie — Create a home that's uniquely yours with Narchie. Shop sustainably, minimize waste, and find one-of-a-kind homeware items.
  • IVO — Platform to allow media owners to deepen advertiser engagement, increase profitability and commercialise ad solutions with ease.
  • Surgery Hero — We combine expert human care, individually-tailored content and cutting edge tech to empower people to take control of their health so they can conquer their surgery.
Show all investments...

Sami Mikati
Angel · 1 investments in United Kingdom Life Science startups

Sami Mikati is a Director of Synthace Ltd. Investor and commercial executive with deep experience and network across energy and engineering industries in Europe, the Middle East and Africa.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Life Science
  • Stage:Seed
  • Geography: India, United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • CyGenica — CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics.
  • Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
Show all investments...

Life Science Angel investor funding in United Kingdom at a glance

Stats across 40 deals from 47 investors.

47
investors
in United Kingdom Life Science startups
40
deals
in United Kingdom Life Science startups
$1.9M
median round
in United Kingdom Life Science startups
9%
lead investors
lead at least one round
48%
Seed
most common funding stage

Access all 47 angel investors in United Kingdom Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Angel Investors in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 47 angel investors investing in United Kingdom Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists